Companies: 10,795·Total market cap: $144.5T

Bio-Techne Corporation

Bio-Techne Corporation

TECHNASDAQHealthcare● Active

$51.99

$-1.19(-2.24%)

Market Cap$8.1B

P/E Ratio—

52W High$72.16

52W Low$43.2

Avg Volume2.6M

Open$53.04

Beta1.36

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Bio-Techne Corporation（TECH）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TECH · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.71Earnings history

PE Ratio (TTM)73.2×PE Ratio deep dive

Revenue (TTM)$1.2BFull revenue history

Dividend Yield0.72%Dividend history

Shares Outstanding157.5MShares outstanding history

Next EarningsAug 5, 2026Est.Earnings history

探索 Bio-Techne Corporation 数据

分析师预测$60 · Buy

营收$1.2B+5.23%

盈利EPS $0.47-56.07%

市盈率73.2×

财务快照

FY 2025Revenue$1.22B▲ +5.23% YoY

202320242025

FY 2025Net Income$73.4M▼ 56.34% YoY

202320242025

FY 2025EPS$0.47▼ 56.07% YoY

202320242025

TTM:Revenue: $1.21BNet Income: $109.6MEPS: $0.71View income statement →

分析师评级与目标价

Buy25 位分析师

Strong Buy

0

Buy

18

Hold

7

Sell

0

Strong Sell

0

12-Month Price Target

$49.00Low

$51.99Current

$60.33Avg Target上涨空间 16.04%

$79.00High

合计: 25 · 买入占比: 72.0%

根据过去 3 个月内 25 位华尔街分析师，TECH 共识评级为 Buy，12 个月平均目标价 $60.33 （较现价 $51.99 上涨空间 16.04%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Bio-Techne Corporation

$51.99-2.24%$8.1B #2

BioMarin Pharmaceutical Inc.

$56.77+0.53%$11.0B #3

Caris Life Sciences, Inc.

$16.49-4.57%$4.7B #4

Corcept Therapeutics Incorporated

$72.62-3.03%$7.8B #5

$52.70+0.40%$13.2B #6

Jazz Pharmaceuticals plc

$238.57-0.62%$15.0B

股票表现

1D-2.24%

1W+4.86%

1M+7.51%

3M-3.53%

YTD-11.60%

1Y+4.23%

5Y-51.07%

关于 Bio-Techne Corporation

CEOKim Kelderman

IPO DateFeb 9, 1989

Employees3,100

CountryUS

Websitebio-techne.com

Bio-Techne Corporation together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. T…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Bio-Techne Corporation（TECH）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 9, 1989 在 NASDAQ 上市。截至最近交易日，TECH 股价为 $51.99，市值约为 $8.1B。过去12个月累计回报 +4.23%，年初至今回报 -11.60%。

根据 25 位华尔街分析师，Bio-Techne Corporation 股票共识评级为Buy，12个月平均目标价为 $60.33。2025 财年 Bio-Techne Corporation 营收 $1.2B，净利润 $73.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Bio-Techne Corporation（TECH）股价为 $51.99，在 NASDAQ 上市，52周区间为 $43.20 – $72.16。

TECH 最新股价TECH quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议